BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22709747)

  • 1. Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF.
    Hauptman PJ; Schwartz PJ; Gold MR; Borggrefe M; Van Veldhuisen DJ; Starling RC; Mann DL
    Am Heart J; 2012 Jun; 163(6):954-962.e1. PubMed ID: 22709747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagus nerve stimulation: A new approach to reduce heart failure.
    Klein HU; Ferrari GM
    Cardiol J; 2010; 17(6):638-44. PubMed ID: 21154273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial.
    Gold MR; Van Veldhuisen DJ; Hauptman PJ; Borggrefe M; Kubo SH; Lieberman RA; Milasinovic G; Berman BJ; Djordjevic S; Neelagaru S; Schwartz PJ; Starling RC; Mann DL
    J Am Coll Cardiol; 2016 Jul; 68(2):149-58. PubMed ID: 27058909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model.
    Zhang Y; Popovic ZB; Bibevski S; Fakhry I; Sica DA; Van Wagoner DR; Mazgalev TN
    Circ Heart Fail; 2009 Nov; 2(6):692-9. PubMed ID: 19919995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autonomic regulation therapy for the improvement of left ventricular function and heart failure symptoms: the ANTHEM-HF study.
    Dicarlo L; Libbus I; Amurthur B; Kenknight BH; Anand IS
    J Card Fail; 2013 Sep; 19(9):655-60. PubMed ID: 24054343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure.
    De Ferrari GM; Crijns HJ; Borggrefe M; Milasinovic G; Smid J; Zabel M; Gavazzi A; Sanzo A; Dennert R; Kuschyk J; Raspopovic S; Klein H; Swedberg K; Schwartz PJ;
    Eur Heart J; 2011 Apr; 32(7):847-55. PubMed ID: 21030409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and study design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF.
    De Ferrari GM; Tuinenburg AE; Ruble S; Brugada J; Klein H; Butter C; Wright DJ; Schubert B; Solomon S; Meyer S; Stein K; Ramuzat A; Zannad F
    Eur J Heart Fail; 2014 Jun; 16(6):692-9. PubMed ID: 24846173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure as an autonomic nervous system dysfunction.
    Kishi T
    J Cardiol; 2012 Mar; 59(2):117-22. PubMed ID: 22341431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vagal stimulation for heart diseases: from animals to men. - An example of translational cardiology.-.
    Schwartz PJ
    Circ J; 2011; 75(1):20-7. PubMed ID: 21127379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of symptomatic and functional responses to vagus nerve stimulation in ANTHEM-HF, INOVATE-HF, and NECTAR-HF.
    Anand IS; Konstam MA; Klein HU; Mann DL; Ardell JL; Gregory DD; Massaro JM; Libbus I; DiCarlo LA; Udelson JJE; Butler J; Parker JD; Teerlink JR
    ESC Heart Fail; 2020 Feb; 7(1):75-83. PubMed ID: 31984682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autonomic regulation therapy via left or right cervical vagus nerve stimulation in patients with chronic heart failure: results of the ANTHEM-HF trial.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Dixit S; Libbus I; DiCarlo LA; Ardell JL; Rector TS; Amurthur B; KenKnight BH; Anand IS
    J Card Fail; 2014 Nov; 20(11):808-16. PubMed ID: 25187002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paced left ventricular QRS width and ECG parameters predict outcomes after cardiac resynchronization therapy: PROSPECT-ECG substudy.
    Hsing JM; Selzman KA; Leclercq C; Pires LA; McLaughlin MG; McRae SE; Peterson BJ; Zimetbaum PJ
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):851-7. PubMed ID: 21956038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
    Bristow MR; Saxon LA; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; DeMets D; White BG; DeVries DW; Feldman AM;
    N Engl J Med; 2004 May; 350(21):2140-50. PubMed ID: 15152059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
    Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
    J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats.
    Li M; Zheng C; Sato T; Kawada T; Sugimachi M; Sunagawa K
    Circulation; 2004 Jan; 109(1):120-4. PubMed ID: 14662714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagal stimulation in heart failure.
    De Ferrari GM
    J Cardiovasc Transl Res; 2014 Apr; 7(3):310-20. PubMed ID: 24500409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.